Back
Alnylam Pharmaceuticals Stock Predictions
Sponsored
ALNY
Sponsored
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
275.08
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Alnylam Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 38.3% based on the past 20 years of stock performance.
- Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Alnylam Pharmaceuticals Stock Undervalued?
The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal. - ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 38.3% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
- Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
287.55
52-Week Low:
141.98
Prediction Charts
Market Cap:
35.29B
Price in USD:
274.91
Volume:
459.53K
Beta:
1.20
Technical Analysis
SMA50:
262.48
SMA100:
224.61
SMA200:
194.67
52-Wk Change:
55.44%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?
Yes, Alnylam Pharmaceuticals is a publicly traded company. -
What is the Alnylam Pharmaceuticals stock quote today?
The Alnylam Pharmaceuticals stock price is 274.91 USD today. -
How to buy Alnylam Pharmaceuticals stock online?
You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-10 | 251.13 | 256.21 | 257.00 | 249.89 |
Sep-11 | 256.75 | 261.86 | 263.65 | 256.11 |
Sep-12 | 260.42 | 261.73 | 266.80 | 259.99 |
Sep-13 | 261.00 | 265.27 | 265.52 | 259.01 |
Sep-16 | 266.66 | 270.37 | 271.16 | 264.37 |
Sep-17 | 271.21 | 274.46 | 274.57 | 270.24 |
Sep-18 | 275.55 | 273.15 | 277.59 | 271.38 |
Sep-19 | 276.53 | 276.33 | 279.85 | 273.53 |
Sep-20 | 275.39 | 273.88 | 275.39 | 270.17 |
Sep-23 | 275.22 | 271.83 | 275.74 | 270.97 |
Sep-24 | 271.56 | 270.87 | 271.66 | 267.13 |
Sep-25 | 271.61 | 272.73 | 275.11 | 268.34 |
Sep-26 | 271.84 | 274.57 | 278.24 | 270.84 |
Sep-27 | 275.50 | 274.91 | 276.07 | 271.48 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.